MedPage Today on MSN
'Most Compelling' Data Yet for Metastasis-Directed Therapy in Prostate Cancer
But an association with improved overall survival failed to reach statistical significance ...
Metastasis-directed therapy (MDT) delivered via stereotactic body radiotherapy has gained substantial attention over the past decade. Landmark trials such as STOMP1 and ORIOLE2 fundamentally shifted ...
Prostate-specific antigen (PSA) is a protein produced by both normal and cancerous cells in the prostate gland. It is primarily measured through a blood test, where normal levels are typically found ...
MedPage Today on MSN
Single Midlife PSA Test May Identity Long-Term Prostate Cancer Risk
Many men with low levels could be spared from invasive procedures and frequent testing ...
Researchers assess the adequacy of tissue ablation by a cooled laser therapy in patients with localized prostate cancer.
A prostate-specific antigen (PSA) test is a blood test that measures a protein released in the blood by prostate cells. Both normal and cancerous prostate cells release the protein. Most of the time, ...
A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, leading to earlier diagnosis and more successful treatment. Prostate cancer is ...
How unfavorable is AUA unfavorable intermediate-risk prostate cancer? Results from a large, institutional cohort. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果